Modulating co-stimulation

Por Viglietta, Vissia, Khoury, Samia J.
Publicado no Neurotherapeutics (2007)

GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes

Por Viglietta, Vissia, Kent, Sally C., Orban, Tihamer, Hafler, David A.
Publicado em 2002

GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes

Por Viglietta, Vissia, Kent, Sally C., Orban, Tihamer, Hafler, David A.
Publicado em 2002

Loss of Functional Suppression by CD4(+)CD25(+) Regulatory T Cells in Patients with Multiple Sclerosis

Por Viglietta, Vissia, Baecher-Allan, Clare, Weiner, Howard L., Hafler, David A.
Publicado em 2004

Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis

Por Calkwood, Jonathan, Vollmer, Timothy, Fox, Robert J., Zhang, Ray, Novas, Mark, Sheikh, Sarah I., Viglietta, Vissia
Publicado no Int J MS Care (2016)

Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients

Por Viglietta, Vissia, Shi, Fuxin, Hu, Qi-Ying, Ren, Yong, Keilty, John, Wolff, Heather, McCarthy, Ryan, Kropp, Jason, Weber, Pete, Soglia, John
Publicado no Invest New Drugs (2020)

Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate

Por Phillips, J. Theodore, Selmaj, Krzysztof, Gold, Ralf, Fox, Robert J., Havrdova, Eva, Giovannoni, Gavin, Abourjaily, Heather, Pace, Amy, Novas, Mark, Hotermans, Christophe, Viglietta, Vissia, Meltzer, Leslie
Publicado no Int J MS Care (2015)

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

Por Quintana, Francisco J., Farez, Mauricio F., Viglietta, Vissia, Iglesias, Antonio H., Merbl, Yifat, Izquierdo, Guillermo, Lucas, Miguel, Basso, Alexandre S., Khoury, Samia J., Lucchinetti, Claudia F., Cohen, Irun R., Weiner, Howard L.
Publicado em 2008

A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis

Por Khoury, Samia J., Healy, Brian C., Kivisäkk, Pia, Viglietta, Vissia, Egorova, Svetlana, Guttmann, Charles R. G., Wedgwood, Josiah F., Hafler, David A., Weiner, Howard L., Buckle, Guy, Cook, Sandra, Reddy, Susheel
Publicado em 2010

Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials

Por Viglietta, Vissia, Miller, David, Bar-Or, Amit, Phillips, J Theodore, Arnold, Douglas L, Selmaj, Krzysztof, Kita, Mariko, Hutchinson, Michael, Yang, Minhua, Zhang, Ray, Dawson, Katherine T, Sheikh, Sarah I, Fox, Robert J, Gold, Ralf
Publicado no Ann Clin Transl Neurol (2015)

Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience

Por Gold, Ralf, Phillips, J. Theodore, Havrdova, Eva, Bar-Or, Amit, Kappos, Ludwig, Kim, Norman, Thullen, Tim, Valencia, Patricia, Oliva, Lauren, Novas, Mark, Li, Jie, Sweetser, Marianne T., Kurukulasuriya, Nuwan, Viglietta, Vissia, Fox, Robert J.
Publicado no Neurol Ther (2015)

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study

Por Miller, David H., Fox, Robert J., Phillips, J. Theodore, Hutchinson, Michael, Havrdova, Eva, Kita, Mariko, Wheeler-Kingshott, Claudia A.M., Tozer, Daniel J., MacManus, David G., Yousry, Tarek A., Goodsell, Mary, Yang, Minhua, Zhang, Ray, Viglietta, Vissia, Dawson, Katherine T.
Publicado no Neurology (2015)

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease

Por Lopez Lopez, Cristina, Tariot, Pierre N., Caputo, Angelika, Langbaum, Jessica B., Liu, Fonda, Riviere, Marie-Emmanuelle, Langlois, Carolyn, Rouzade-Dominguez, Marie-Laure, Zalesak, Martin, Hendrix, Suzanne, Thomas, Ronald G., Viglietta, Vissia, Lenz, Rob, Ryan, J. Michael, Graf, Ana, Reiman, Eric M.
Publicado no Alzheimers Dement (N Y) (2019)

Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8(low) cells

Por De Jager, Philip L., Rossin, Elizabeth, Pyne, Saumyadipta, Tamayo, Pablo, Ottoboni, Linda, Viglietta, Vissia, Weiner, Mira, Soler, Dulce, Izmailova, Elena, Faron-Yowe, Lauren, O’Brien, Carmeline, Freeman, Sam, Granados, Susana, Parker, Alex, Roubenoff, Ronenn, Mesirov, Jill P., Khoury, Samia J., Hafler, David A., Weiner, Howard L.
Publicado em 2008

Age-dependent B cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis

Por McLaughlin, Katherine A., Chitnis, Tanuja, Newcombe, Jia, Franz, Bettina, Kennedy, Julia, McArdel, Shannon, Kuhle, Jens, Kappos, Ludwig, Rostasy, Kevin, Pohl, Daniela, Gagne, Donald, Ness, Jayne M., Tenembaum, Silvia, O'Connor, Kevin C., Viglietta, Vissia, Wong, Susan J., Tavakoli, Norma P., de Seze, Jerome, Khoury, Samia J., Bar-Or, Amit, Hafler, David A., Banwell, Brenda, Wucherpfennig, Kai W.
Publicado em 2009

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

Por O’Connor, Kevin C, McLaughlin, Katherine A, De Jager, Philip L, Chitnis, Tanuja, Bettelli, Estelle, Xu, Chenqi, Robinson, William H, Cherry, Sunil V, Bar-Or, Amit, Banwell, Brenda, Fukaura, Hikoaki, Fukazawa, Toshiyuki, Tenembaum, Silvia, Wong, Susan J, Tavakoli, Norma P, Idrissova, Zhannat, Viglietta, Vissia, Rostasy, Kevin, Pohl, Daniela, Dale, Russell C, Freedman, Mark, Steinman, Lawrence, Buckle, Guy J, Kuchroo, Vijay K, Hafler, David A, Wucherpfennig, Kai W
Publicado em 2007